Advert - Consilient – AUTH/3403/10/20
Promotion of InVita D3 via an app
-
Date posted02 August 2021
-
SanctionAdvertisement,
-
Case number/s
For allowing members of the public to view, within an app store, promotional information for InVita D3 (colecalciferol) on an app which was intended for health professionals, and for not re-certifying promotional material within two years, Consilient was ruled in breach of the following clauses of the Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 9.1 - Failing to maintain high standards
Clause 14.5 - Using material for more than two years without re-certification
Clause 26.1 - Advertising a prescription only medicine to the public